BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models

Yuki Kagoya(Institute for Advanced Medical Research), Naoto Hirano(University Health Network)
Journal of Clinical Investigation
August 21, 2016
Cited by 214


Related Papers